Anterior cervical discectomy and fusion

AlloSource Announces First Patients Implanted With AlloWrap Amniotic Membrane In Clinical Study For Two-Level Anterior Cervical Discectomy And Fusion Procedures

Tuesday, February 23, 2021 - 6:40pm

The primary objective of this study is to obtain evidence of the effectiveness of AlloWrap Amniotic Membrane in the reduction of soft tissue swelling in two-level ACDF procedures.

Key Points: 
  • The primary objective of this study is to obtain evidence of the effectiveness of AlloWrap Amniotic Membrane in the reduction of soft tissue swelling in two-level ACDF procedures.
  • "Though I have performed many successful anterior cervical discectomy and fusion procedures, I am always looking for ways to improve patient outcomes," said Dr. Paul Kim with The Spine Institute of San Diego.
  • AlloSource's AlloWrap is a human amniotic membrane designed to provide a biologic barrier following surgical repair in a multitude of procedures.
  • Founded in 1994, AlloSource is a nonprofit leader in providing allografts that maximize tissue donation to help surgeons heal their patients.

Synergy Disc® Announces Enrollment of First Patient in US IDE Clinical Trial

Friday, January 29, 2021 - 2:00pm

Synergy Disc Replacement Ltd., a Colorado-based spinal medical device company and wholly owned subsidiary of Synergy Disc Replacement Inc. (SDRi), announced today that it has enrolled the first patient in its U.S. IDE clinical trial.

Key Points: 
  • Synergy Disc Replacement Ltd., a Colorado-based spinal medical device company and wholly owned subsidiary of Synergy Disc Replacement Inc. (SDRi), announced today that it has enrolled the first patient in its U.S. IDE clinical trial.
  • The Synergy Disc trial is a multi-center, prospective, historically controlled study that will be conducted on 175 patients at up to 15 sites in the U.S.
  • This trial is designed to demonstrate that the Synergy Disc is at least as safe and effective as conventional anterior cervical discectomy and fusion in patients with one-level symptomatic cervical degenerative disc disease (DDD).
  • at Austin Neurosurgeons in Austin, Texas has performed the first surgery utilizing the Synergy Disc in the United States.

NuVasive Expands Proprietary Porous PEEK Portfolio with Cohere XLIF Interbody

Wednesday, November 18, 2020 - 1:33pm

Cohere XLIF is a key addition to NuVasive's Advanced Materials Science (AMS) implant portfolio, consisting of proprietary surface and structural technologies, and is designed for bone in-growth while maintaining the imaging and mechanical properties favored in smooth PEEK and titanium coated PEEK interbody devices.

Key Points: 
  • Cohere XLIF is a key addition to NuVasive's Advanced Materials Science (AMS) implant portfolio, consisting of proprietary surface and structural technologies, and is designed for bone in-growth while maintaining the imaging and mechanical properties favored in smooth PEEK and titanium coated PEEK interbody devices.
  • "Combined with Cohere XLIF, the Cohere XLIF AMS plate equips surgeons with additional technology when pathologic features call for it and gives confidence in a patient's path to returning to normal activities."
  • The Porous PEEK technology in Cohere XLIF has been recently studied head to head in cervical spine fusion against smooth PEEK and structural allograft bone.
  • Early clinical outcomes comparing porous PEEK, smooth PEEK, and structural allograft interbody devices for anterior cervical discectomy and fusion.

CoreLink Announces FDA Clearance of F3D-C2 Stand-alone Cervical Spine System

Tuesday, June 30, 2020 - 12:20pm

CoreLink, LLC , a leading designer and manufacturer of spinal implant systems, today announced the commercial launch and 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the F3D-C2 Stand-alone Cervical System .

Key Points: 
  • CoreLink, LLC , a leading designer and manufacturer of spinal implant systems, today announced the commercial launch and 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the F3D-C2 Stand-alone Cervical System .
  • View the full release here: https://www.businesswire.com/news/home/20200630005144/en/
    The F3D-C2 Stand-alone Cervical Spine System features an additively manufactured spacer with two bone screw anchors secured by a locking mechanism printed within the cage.
  • Stand-alone cervical devices eliminate the need for a supplemental fixation plate, making anterior cervical discectomy and fusion (ACDF) procedures easier and faster to complete.
  • The F3D-C2 Stand-alone Cervical System features the only 3D printed spine technology with both a trabecular structure and directional support lattices designed to allow for fusion throughout the entire implant, said Jay Bartling, CEO of CoreLink.

Providence Medical Technology Announces First Patient Enrollment in the "FUSE" IDE Clinical Study

Monday, June 15, 2020 - 11:00am

The study is designed to demonstrate that Circumferential Cervical Fusion (CCF) achieves superior clinical outcomes versus ACDF for the treatment of 3-level cervical degenerative disc disease.

Key Points: 
  • The study is designed to demonstrate that Circumferential Cervical Fusion (CCF) achieves superior clinical outcomes versus ACDF for the treatment of 3-level cervical degenerative disc disease.
  • Providence CEO & Co-founder, Jeff Smith, explained the importance of the FUSE Study: "Our purpose at Providence is to improve clinical outcomes for high-risk patients and prevent surgical failures of the cervical spine.
  • The FUSE Study is an important next step towards that goal, and we are grateful for the support and dedication of our clinical investigators."
  • Providence Medical Technology, Inc. is a privately held medical device company focused on innovative and tissue-sparing surgical solutions for cervical spine surgery.

RTI Surgical® Announces Commercial Launch of the CervAlign® Anterior Cervical Plate System

Tuesday, September 24, 2019 - 12:05pm

DEERFIELD, Ill., Sept. 24, 2019 (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced the full commercial launch of the CervAlign Anterior Cervical Plate (ACP) System to add to the growth of its Established Therapies spine portfolio.

Key Points: 
  • DEERFIELD, Ill., Sept. 24, 2019 (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced the full commercial launch of the CervAlign Anterior Cervical Plate (ACP) System to add to the growth of its Established Therapies spine portfolio.
  • The CervAlign ACP System is designed to promote cervical fusion by providing temporary resistance to flexion, extension, lateral bending and axial rotation with strength and stiffness in the cervical spine (C2-C7).
  • The system includes implants of various plate and screw sizes to accommodate varying patient anatomies.
  • Additionally, using the Fortilink-C Interbody Fusion (IBF) System with TETRAfuse 3D Technology and ViBone Viable Bone Matrix with the CervAlign ACP provides surgeons a complete anterior cervical discectomy and fusion (ACDF) solution.

NuVasive Expands Cervical Advanced Materials Science™ Portfolio with Launch of Porous Titanium Implant

Thursday, September 5, 2019 - 1:33pm

The availability of Modulus Cervical expands the Company's Advanced Materials Science(AMS) portfolio to include both Porous PEEKand porous titanium offerings for anterior cervical discectomy and fusion (ACDF) techniques, a commonly performed surgery to address cervical disc degeneration or spinal instability.

Key Points: 
  • The availability of Modulus Cervical expands the Company's Advanced Materials Science(AMS) portfolio to include both Porous PEEKand porous titanium offerings for anterior cervical discectomy and fusion (ACDF) techniques, a commonly performed surgery to address cervical disc degeneration or spinal instability.
  • NuVasive's Modulus offerings are part of the Company's AMS portfolio that represent the future of porous implant technologies.
  • "These characteristics, combined with the implant's porous surface technology, are unmatched compared to other cervical interbodies on the market."
  • "NuVasive's expanded AMS portfolio for cervical applications provides surgeons with additional solutions to select the right material for their patient," said Matt Link, president of NuVasive.

NuVasive Proprietary Porous PEEK™ Technology Used In First XLIF® Spine Surgery Cases

Monday, April 1, 2019 - 1:30pm

SAN DIEGO, April 1, 2019 /PRNewswire/ --NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the first-case uses of CohereXLIF, the first-of-its-kind lateral Porous PEEK implant for XLIF and lateral single-position surgery.

Key Points: 
  • SAN DIEGO, April 1, 2019 /PRNewswire/ --NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the first-case uses of CohereXLIF, the first-of-its-kind lateral Porous PEEK implant for XLIF and lateral single-position surgery.
  • The NuVasive Advanced Materials Science implant portfolio will remain on the forefront of innovation by incorporating Porous PEEK technology into its implants for lateral single-position surgery and beyond.
  • Cohere XLIF is the first product launch for XLIF and lateral single-position surgery applications using Porous PEEK technology.
  • Early clinical outcomes comparing porous PEEK, smooth PEEK, and structural allograft interbody devices for anterior cervical discectomy and fusion.